“Even with all of the advances in diabetes technology, insulin therapy is still overwhelming and complex,” said Mike Mason, who heads Lilly’s connected care and insulins programme. Bundling ...

Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced and unlikely to make it to market for several ...

The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...

In 2024, drug makers lowered the cost of dozens of common medications to avoid penalties imposed by the American Rescue Plan, Katie Thomas of ...

The health-care sector has been rebounding recently following a sharp selloff in recent weeks amid hopes that controversy would die down. The health-care industry group was among the leading S&P 500 ...

Rimidi's system will be targeted at primary care providers, allowing them to use analytics and platforms, such as Lilly's integrated insulin management system, to improve care for specific patient ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

Shares of Eli Lilly and Co. fell more than 7% in midday trading Tuesday after the Indianapolis company announced its fourth ...

The Huminsulin range is vital for managing both type 1 and type 2 diabetes, helping control blood sugar levels in adults and ...

Health-care companies slid after a profit warning from Eli Lilly. Shares of the obesity ... revenue as the market for drugs that increase insulin levels grew more slowly than expected.